Relationships between NT-proBNP and Obesity, Glucose and Lipid Profiles in Dogs with Chronic Mitral Valve Insufficiency

다국어 초록 (Multilingual Abstract)

In humans, N-terminal pro-B-type natriuretic peptide (NT-proBNP) was shown to be inversely related to obesity; in addition, its association with contributing factors for obesity such as insulin, lipids, and glucose profiles has been demonstrated in the literature. However, this association between NT-proBNP and the severity of obesity has not been investigated in veterinary medicine. Our study hypothesis is that plasma levels of NT-proBNP may be related to body condition score (BCS) and contributing factors to obesity in dogs with heart diseases. To achieve our study goal, we collected blood samples from 73 client-owned dogs of small breeds at different stages of heart failure due to chronic mitral valvular insufficiency (CMVI). Fasting glucose concentrations, lipid profiles (i.e., total triglycerides [TG], total cholesterol [TC], high-density lipoprotein cholesterol [HDL-C], low-density lipoprotein cholesterol [LDLC]),fructosamine, insulin and NT-proBNP concentrations were measured. The insulin/glucose ratio was also determined.
NT-proBNP showed not only a significant correlation with the severity of CMVI related heart failure but also an inverse relationship to body condition scores (BCS), insulin plasma levels and fructosamine concentrations. We found the presence of an inverse relationship between plasma levels of NT-proBNP and the severity of obesity. In addition, NTproBNP was associated with lower levels of contributing factors to obesity such as fructosamine and insulin, creating a possible link between the obesity and NT-proBNP in dogs with heart disease. This is also the first report demonstrating an inverse association between obesity and NT-proBNP in dogs with heart failure.

참고문헌 (Reference)

1 Kanda H, "What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population" 19 : 165-172, 2005

2 Bayes-Genis A, "Understanding amino-terminal pro-B-type natriuretic peptide in obesity" 101 : 89-94, 2008

3 Oyama MA, "The use of NT-proBNP assay in the management of canine patients with heart disease" 40 : 545-558, 2010

4 Boswood A, "The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease" 49 : 26-32, 2008

5 Puavilai W, "The accuracy in using modified Friedewald equation to calculate LDL from non-fast triglyceride: a pilot study" 92 : 182-187, 2009

6 Kalra PR, "Regulation of lipolysis: natriuretic peptides and the development of cachexia" 85 : 125-132, 2002

7 Tarnow I, "Predictive value of natriuretic peptides in dogs with mitral valve disease" 180 : 195-201, 2009

8 Serres F, "Plasma N-terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission" 11 : 103-121, 2009

9 Guyard-Dangremont V, "Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility" 120 : 517-525, 1998

10 Sengenès C, "Natriuretic peptides: a new lipolytic pathway in human adipocytes" 14 : 1345-1351, 2000

11 Potter LR, "Natriuretic peptide metabolism, clearance and degradation" 278 : 1808-1817, 2011

12 Olsen MH, "N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome" 46 : 660-666, 2005

13 Moonarmart W, "N-terminal pro B-type natriuretic peptide and left ventricular diameter independently predict mortality in dogs with mitral valve disease" 51 : 84-96, 2010

14 Maldonado EN, "Major plasma lipids and fatty acids in four HDL mammals" 132 : 297-303, 2002

15 Bailhache E, "Lipoproteins abnormalities in obese insulinresistant dogs" 52 : 559-564, 2003

16 Jensen MD, "Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine" 79 : 207-213, 1987

17 Maldonado EN, "Lipid and fatty acid composition of canine lipoproteins" 128 : 719-729, 2001

18 Hess RS, "Insulin resistance in dogs" 40 : 309-316, 2010

19 Scott-Moncrieff JC., "Insulin resistance in cats" 40 : 241-257, 2010

20 Wang TJ, "Impact of obesity on plasma natriuretic peptide levels" 109 : 594-600, 2004

21 Das SR, "Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study" 112 : 2163-2168, 2005

22 Wang TJ, "Impact of age and sex on plasma natriuretic peptide levels in healthy adults" 90 : 254-258, 2002

23 Atkins C, "Guidelines for the diagnosis and treatment of canine chronic valvular heart disease" 23 : 1142-1150, 2009

24 Sarzani R, "Expression of natriuretic peptide receptors in human adipose and other tissues" 19 : 581-585, 1996

25 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)" 285 : 2486-2497, 2001

26 Takemura N, "Evaluation of plasma N-terminal probrain natriuretic peptide (NT-proBNP) concentrations in dogs with mitral valve insufficiency" 71 : 925-929, 2009

27 Moro C, "Differential regulation of atrial natriuretic peptide- and adrenergic receptordependent lipolytic pathways in human adipose tissue" 54 : 122-131, 2005

28 Laflamme D, "Development and validation of a body condition score system for dogs" 22 : 12-15, 1997

29 Grundy SM, "Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition" 109 : 433-438, 2004

30 Oyama MA, "Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity" 232 : 1496-1503, 2008

31 Boswood A, "Biomarkers in cardiovascular disease: beyond natriuretic peptides" 11 : 23-32, 2009

32 Chetboul V, "Association of plasma N-terminal pro-B-type natriuretic peptide concentration with mitral regurgitation severity and outcome in dogs with asymptomatic degenerative mitral valve disease" 23 : 984-994, 2009

33 Xenoulis PG, "Association of hypertriglyceridemia with insulin resistance in healthy Miniature Schnauzers" 238 : 1011-1016, 2011

34 Veiga AP, "Association of canine obesity with reduced serum levels of C-reactive protein" 20 : 224-228, 2008

35 Li WY, "Association of amino-terminal pro-brain natriuretic peptide with metabolic syndrome" 50 : 1143-1147, 2011

36 Siervo M, "Angiogenesis and biomarkers of cardiovascular risk in adults with metabolic syndrome" 268 : 338-347, 2010